155 related articles for article (PubMed ID: 29856219)
1. Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides.
Roy J; Watson JE; Hong IS; Fan TM; Das A
J Med Chem; 2018 Jul; 61(13):5569-5579. PubMed ID: 29856219
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory ω-3 endocannabinoid epoxides.
McDougle DR; Watson JE; Abdeen AA; Adili R; Caputo MP; Krapf JE; Johnson RW; Kilian KA; Holinstat M; Das A
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6034-E6043. PubMed ID: 28687674
[TBL] [Abstract][Full Text] [Related]
3. Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers.
Carnevale LN; Das A
Adv Exp Med Biol; 2019; 1161():219-232. PubMed ID: 31562632
[TBL] [Abstract][Full Text] [Related]
4. Biocatalytic regio- and stereoselective access to ω-3 endocannabinoid epoxides with peroxygenase from oat flour.
Sanfilippo C; Patti A
Bioorg Chem; 2021 Aug; 113():105014. PubMed ID: 34077840
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide.
Rand AA; Helmer PO; Inceoglu B; Hammock BD; Morisseau C
Methods Mol Biol; 2018; 1730():123-133. PubMed ID: 29363071
[TBL] [Abstract][Full Text] [Related]
6. Targeting the endocannabinoid system as a potential anticancer approach.
Schwarz R; Ramer R; Hinz B
Drug Metab Rev; 2018 Feb; 50(1):26-53. PubMed ID: 29390896
[TBL] [Abstract][Full Text] [Related]
7. 5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells.
Park SW; Hah JH; Oh SM; Jeong WJ; Sung MW
BMC Cancer; 2016 Jul; 16():458. PubMed ID: 27411387
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
[TBL] [Abstract][Full Text] [Related]
9. Synthetic ω-3 epoxyfatty acids as antiproliferative and pro-apoptotic agents in human breast cancer cells.
Dyari HR; Rawling T; Bourget K; Murray M
J Med Chem; 2014 Sep; 57(17):7459-64. PubMed ID: 25144895
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
11. Emerging class of omega-3 fatty acid endocannabinoids & their derivatives.
Watson JE; Kim JS; Das A
Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106337. PubMed ID: 31085370
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes.
Wojtalla A; Herweck F; Granzow M; Klein S; Trebicka J; Huss S; Lerner R; Lutz B; Schildberg FA; Knolle PA; Sauerbruch T; Singer MV; Zimmer A; Siegmund SV
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G873-87. PubMed ID: 22301114
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.
Palumbo-Zerr K; Horn A; Distler A; Zerr P; Dees C; Beyer C; Selvi E; Cravatt BF; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Dec; 71(12):2051-4. PubMed ID: 22915616
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Endocannabinoids in Alcohol "Binge" Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists.
Zhou Y; Huang T; Lee F; Kreek MJ
Alcohol Clin Exp Res; 2016 Mar; 40(3):467-73. PubMed ID: 26857901
[TBL] [Abstract][Full Text] [Related]
16. Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition.
Pu S; Eck P; Jenkins DJ; Connelly PW; Lamarche B; Kris-Etherton PM; West SG; Liu X; Jones PJ
Br J Nutr; 2016 Mar; 115(6):1012-23. PubMed ID: 26806592
[TBL] [Abstract][Full Text] [Related]
17. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.
Ortar G; Cascio MG; Moriello AS; Camalli M; Morera E; Nalli M; Di Marzo V
Eur J Med Chem; 2008 Jan; 43(1):62-72. PubMed ID: 17452063
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid amide hydrolase (FAAH) inhibitor PF-3845 reduces viability, migration and invasiveness of human colon adenocarcinoma Colo-205 cell line: an in vitro study.
Wasilewski A; Krajewska U; Owczarek K; Lewandowska U; Fichna J
Acta Biochim Pol; 2017; 64(3):519-525. PubMed ID: 28850633
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase.
Vila A; Rosengarth A; Piomelli D; Cravatt B; Marnett LJ
Biochemistry; 2007 Aug; 46(33):9578-85. PubMed ID: 17649977
[TBL] [Abstract][Full Text] [Related]
20. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity.
Karanian DA; Brown QB; Makriyannis A; Kosten TA; Bahr BA
J Neurosci; 2005 Aug; 25(34):7813-20. PubMed ID: 16120783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
